You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
|
|---|---|
| Published in |
The Lancet, January 2012
|
| DOI | 10.1016/s0140-6736(11)61619-x |
| Pubmed ID | |
| Authors |
Neil E Fleshner, M Scott Lucia, Blair Egerdie, Lorne Aaron, Gregg Eure, Indrani Nandy, Libby Black, Roger S Rittmaster |
| Abstract |
We aimed to investigate the safety and efficacy of dutasteride, a 5α-reductase inhibitor, on prostate cancer progression in men with low-risk disease who chose to be followed up with active surveillance. |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 44% |
| Colombia | 1 | 3% |
| France | 1 | 3% |
| Argentina | 1 | 3% |
| Germany | 1 | 3% |
| Belgium | 1 | 3% |
| Japan | 1 | 3% |
| Canada | 1 | 3% |
| Mexico | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 10 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 69% |
| Practitioners (doctors, other healthcare professionals) | 8 | 25% |
| Scientists | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 4 | 2% |
| United Kingdom | 2 | 1% |
| United States | 2 | 1% |
| Netherlands | 1 | <1% |
| Canada | 1 | <1% |
| Colombia | 1 | <1% |
| Denmark | 1 | <1% |
| Slovenia | 1 | <1% |
| Unknown | 158 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 17% |
| Student > Ph. D. Student | 19 | 11% |
| Other | 16 | 9% |
| Student > Postgraduate | 16 | 9% |
| Student > Doctoral Student | 15 | 9% |
| Other | 52 | 30% |
| Unknown | 24 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 88 | 51% |
| Agricultural and Biological Sciences | 9 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 4% |
| Nursing and Health Professions | 4 | 2% |
| Psychology | 4 | 2% |
| Other | 23 | 13% |
| Unknown | 37 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2023.
All research outputs
#682,693
of 25,374,647 outputs
Outputs from The Lancet
#5,837
of 42,669 outputs
Outputs of similar age
#3,829
of 252,184 outputs
Outputs of similar age from The Lancet
#36
of 487 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,669 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,184 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 487 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.